Had you re-invested dividends ? I'm very interested in such a company like this. There growth since 1990's has been outstanding beating GSK hands down until 2009. Where also the FTSE100 has beat this share, as well as the pharma's in general. I like that this company is a specialist company in drugs. (Which i believe in the long run will only increase over the years)This is a very good company being undervalued a lot that when the FTSE100 falls, it will be undervalued more! I would be interested to hear more comments on the company from you Bobsbargains...
well said i have been in az for last 15 years used to work for them first class dividend 8% almost every year not to be sniffed at you could day trade higher risks and perhaps make more (i do but on spare cash) but az is a great one for peace of mind .. i don't agree there r&d is poor and recent acquisitions have been first class . they are way to undervalued 36 was the highest before the big crash over 10 years ago ( almost back at that level ) but they still paid out the important dividend thats why the fund managers stick with them . best of luck..
All companies have blips in their histories its business cycle its sensible to get in on the blips if the company fits investment strategy critera.
for me dividends are everything. i am 24 so x 5% over 50 years (if i live that long). This is a known investing technique everybody has different ways to invest. I've looked at the company and saw that the R+D is terrible. But under £40. this is under valued and unloved. it has everything i am looking for in a share. Thanks for the tip but refrain from insults unless your a child. If they go down below 30 I will buy more. Right now I'm in small time but a company that has grown this much over the years and been virtually static during 2009 in comparison to the FTSE100. its worth a bash.
20 Nov '13
The reason for this being an unloved stock, is simple. Their R&D is terrible. Enough said, and there sales are dropping like bombs, though so are GSK's but not as much. If you want a cheap pharma you should buy NVS, its the cheapest in sector on a price - to - earnings basis. Plus it has over $50bn invested in RHHBY. Dividends mean jack - all! On a growth story, BMY is the beast of all Pharma's and JNJ is 2nd, then PFE.
14 Nov '13
has all the things I'm looking in a share right now. Overlooked. pays 5.5 dividend with a progressive dividend policy and is FTSE 100. I believe because of the US healthcare issues big pharma has been unloved sector. Has not really preformed with the broader market since 2009. I think FTSE + SP may come down a little mid term. But i don't time things. Starting small here then gradually increasing my holding. Can see how unloved this share is per the posts. GLA
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.